Cargando…

β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease

Alzheimer’s disease (AD) and vascular dementia are responsible for up to 90% of dementia cases. According to the World Health Organization (WHO), a staggering number of 35.6 million people are currently diagnosed with dementia. Blocking disease progression or preventing AD altogether is desirable fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Menting, Kelly Willemijn, Claassen, Jurgen A. H. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104928/
https://www.ncbi.nlm.nih.gov/pubmed/25100992
http://dx.doi.org/10.3389/fnagi.2014.00165